Author(s):
Pandey P, Kar PK.
Email(s):
drpradeeppande@gmail.com
DOI:
Not Available
Address:
Pandey P.1* and Kar P. K.2
1Assistant Professor, Surgery, Govt. Medical College, Jagdalpur (Bastar) India
2Professor and H.O.D., Dept. of Dermatology and S.T.D., Govt. Medical College, Jagdalpur (Bastar) India
*Corresponding Author
Published In:
Volume - 5,
Issue - 1,
Year - 2013
ABSTRACT:
Background; World Health Organization (W.H.O.) has warned that India is the next hub for Cancer. Cancer annually kills four lakhs Indians. In developing countries, cancer ranks third as a cause of death and accounts for 9.5 % (3.8 million) of all mortality. Cancer is curable if detected early. The results of treatment in stage I and II (early stage)are about 80%.In late stage diseases (stage III and IV ), the results are less than 20%.In India, about 70%patients are in advanced stage, and are difficult to treat. By 2015, the number of new cases is expected to cross 15 lakhs. Objective: to analysis some of the epidemiological profile of Carcinomas and find the ways and means for prevention and control of the same Material and methods: Eighty-two confirmed cases of carcinomas were included in the study. Study variables: Age, sex and site of cancer lesions Findings and discussion: Out eighty two cases 60.97 % and 39.02 % were male and female respectively. As prostate is found in male only hence all 100 % cases were males while in cases of lump in breast ,out of nineteen cases 84.21 % and 15.78 % were female and male respectively. Regarding Goiter, each belongs 50 % cases to both sexes.
Cite this article:
Pandey P, Kar PK.
Retrospective Study of Epidemiological Profile of Carcinomas.
Research J. Pharmacology and Pharmacodynamics. 2013; 5(1): 58-61.
Cite(Electronic):
Pandey P, Kar PK.
Retrospective Study of Epidemiological Profile of Carcinomas.
Research J. Pharmacology and Pharmacodynamics. 2013; 5(1): 58-61. Available on: https://rjppd.org/AbstractView.aspx?PID=2013-5-1-26